A Drug-drug Interaction Study of Avapritinib and Midazolam
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
A Drug-drug Interaction Study to Investigate the Effect of Avapritinib on the
Pharmacokinetics of Midazolam in Patients with Unresectable or Metastatic Gastrointestinal
Stromal Tumors (GIST)